Condition (MeSH)
Coronary Vasospasm
ClinicalTrials.gov lists 27 trials for Coronary Vasospasm or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
27 of the 27 trials are tagged with Coronary Vasospasm itself; the rest are tagged with a narrower condition beneath it.
When did Coronary Vasospasm trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2023 | 1 |
| 2022 | 5 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 1 |
| 2018 | 2 |
| 2016 | 1 |
| 2014 | 1 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Coronary Vasospasm trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 3 |
| Phase 4 | 2 |
| Not applicable | 9 |
| Observational | 12 |
How many Coronary Vasospasm trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 2 |
| Completed | 12 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Coronary Vasospasm? (5)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| NEBIVOLOL | 1 |
| Adenosine | 1 |
| Acetylcholine | 1 |
| Darapladib | 1 |
| Bisoprolol | 1 |
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 2% Diltiazem | 3 |
| Nebivolol+Diltiazem | 1 |
| single dose Sildenafil | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Coronary Vasospasm trials report? (3)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Angina | 2 | 1 |
| Hematoma in groin | 2 | 1 |
| Chest pain | 1 | 1 |
Which publications cover Coronary Vasospasm? (87)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 87 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.